222 related articles for article (PubMed ID: 20015868)
1. Determinants of participation in colorectal cancer screening with faecal occult blood testing.
von Euler-Chelpin M; Brasso K; Lynge E
J Public Health (Oxf); 2010 Sep; 32(3):395-405. PubMed ID: 20015868
[TBL] [Abstract][Full Text] [Related]
2. Screening for colorectal cancer by faecal occult blood test: why people choose to refuse.
Worthley DL; Cole SR; Esterman A; Mehaffey S; Roosa NM; Smith A; Turnbull D; Young GP
Intern Med J; 2006 Sep; 36(9):607-10. PubMed ID: 16911554
[TBL] [Abstract][Full Text] [Related]
3. Uptake of faecal occult blood test colorectal cancer screening by different ethnic groups in the Netherlands.
Deutekom M; van Rijn AF; Dekker E; Blaauwgeers H; Stronks K; Fockens P; Essink-Bot ML
Eur J Public Health; 2009 Aug; 19(4):400-2. PubMed ID: 19372193
[TBL] [Abstract][Full Text] [Related]
4. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
[TBL] [Abstract][Full Text] [Related]
5. Predictors of colorectal screening in rural Colorado: testing to prevent colon cancer in the high plains research network.
Young WF; McGloin J; Zittleman L; West DR; Westfall JM
J Rural Health; 2007; 23(3):238-45. PubMed ID: 17565524
[TBL] [Abstract][Full Text] [Related]
6. Colorectal cancer mass screening event utilising quantitative faecal occult blood test.
Chew MH; Suzanah N; Ho KS; Lim JF; Ooi BS; Tang CL; Eu KW
Singapore Med J; 2009 Apr; 50(4):348-53. PubMed ID: 19421676
[TBL] [Abstract][Full Text] [Related]
7. Patterns of colorectal cancer screening uptake among men and women in the United States.
Meissner HI; Breen N; Klabunde CN; Vernon SW
Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):389-94. PubMed ID: 16492934
[TBL] [Abstract][Full Text] [Related]
8. Results of the first round of a demonstration pilot of screening for colorectal cancer in the United Kingdom.
UK Colorectal Cancer Screening Pilot Group
BMJ; 2004 Jul; 329(7458):133. PubMed ID: 15237087
[TBL] [Abstract][Full Text] [Related]
9. Colorectal cancer screening using immunochemical faecal occult blood testing in Japan.
Saito H
J Med Screen; 2006; 13 Suppl 1():S6-7. PubMed ID: 17227634
[TBL] [Abstract][Full Text] [Related]
10. "It's a small price to pay for life": faecal occult blood test (FOBT) screening for colorectal cancer, perceived barriers and facilitators.
Reeder AI
N Z Med J; 2011 Mar; 124(1331):11-7. PubMed ID: 21725408
[TBL] [Abstract][Full Text] [Related]
11. The effects of promoting colorectal cancer screening on screening utilisation: evaluation of the German Campaign "Aktiv gegen Darmkrebs" (Action against Colorectal Cancer).
Loss J; Eichhorn C; Nagel E
Z Gastroenterol; 2006 Nov; 44(11):1127-34. PubMed ID: 17115353
[TBL] [Abstract][Full Text] [Related]
12. Predictors of colorectal cancer screening participation in the United States.
Ioannou GN; Chapko MK; Dominitz JA
Am J Gastroenterol; 2003 Sep; 98(9):2082-91. PubMed ID: 14499792
[TBL] [Abstract][Full Text] [Related]
13. Early detection of colorectal cancer with faecal occult blood test screening.
Paimela H; Malila N; Palva T; Hakulinen T; Vertio H; Järvinen H
Br J Surg; 2010 Oct; 97(10):1567-71. PubMed ID: 20603855
[TBL] [Abstract][Full Text] [Related]
14. Low priority main reason not to participate in a colorectal cancer screening program with a faecal occult blood test.
van Rijn AF; van Rossum LG; Deutekom M; Laheij RJ; Fockens P; Bossuyt PM; Dekker E; Jansen JB
J Public Health (Oxf); 2008 Dec; 30(4):461-5. PubMed ID: 18716047
[TBL] [Abstract][Full Text] [Related]
15. Predictors of fecal occult blood test (FOBT) completion among low-income adults.
Greiner KA; James AS; Born W; Hall S; Engelman KK; Okuyemi KS; Ahluwalia JS
Prev Med; 2005 Aug; 41(2):676-84. PubMed ID: 15917068
[TBL] [Abstract][Full Text] [Related]
16. Evidence, efficacy and effectiveness of screening for colorectal cancer with faecal tests.
Faivre J; Lepage C
Z Gastroenterol; 2008 Apr; 46 Suppl 1():S17-9. PubMed ID: 18368633
[No Abstract] [Full Text] [Related]
17. Is it reasonable to use faecal occult blood test for colorectal cancer screening?
Musil D; Tillich J
Acta Univ Palacki Olomuc Fac Med; 1999; 142():119-21. PubMed ID: 10743740
[TBL] [Abstract][Full Text] [Related]
18. Analysis of colorectal cancer stage among HMO members targeted for screening.
Myers RE; Murray J; Weinberg D; McGrory G; Wolf T; Caveny J; Hanchak N; Schlackman N; Comis R
Arch Intern Med; 1997 Sep; 157(17):2001-6. PubMed ID: 9308512
[TBL] [Abstract][Full Text] [Related]
19. Limitations of the faecal occult blood test in screening for colorectal cancer.
Delcò F; Sonnenberg A
Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
[TBL] [Abstract][Full Text] [Related]
20. Obstacles to colorectal screening in general practice: a qualitative study of GPs and patients.
Aubin-Auger I; Mercier A; Lebeau JP; Baumann L; Peremans L; Van Royen P
Fam Pract; 2011 Dec; 28(6):670-6. PubMed ID: 21551256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
